000 01607 a2200421 4500
005 20250514071249.0
264 0 _c20030908
008 200309s 0 0 eng d
022 _a0022-1767
024 7 _a10.4049/jimmunol.170.12.5815
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSchümann, Jens
245 0 0 _aCutting edge: influence of the TCR V beta domain on the avidity of CD1d:alpha-galactosylceramide binding by invariant V alpha 14 NKT cells.
_h[electronic resource]
260 _bJournal of immunology (Baltimore, Md. : 1950)
_cJun 2003
300 _a5815-9 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAnimals
650 0 4 _aAntigens, CD1
_xmetabolism
650 0 4 _aAntigens, CD1d
650 0 4 _aCell Adhesion
_ximmunology
650 0 4 _aDimerization
650 0 4 _aDose-Response Relationship, Immunologic
650 0 4 _aGalactosylceramides
_xmetabolism
650 0 4 _aHumans
650 0 4 _aKiller Cells, Natural
_ximmunology
650 0 4 _aMice
650 0 4 _aMice, Inbred C57BL
650 0 4 _aPeptide Fragments
_xphysiology
650 0 4 _aProtein Structure, Tertiary
650 0 4 _aReceptors, Antigen, T-Cell, alpha-beta
_xphysiology
650 0 4 _aT-Lymphocyte Subsets
_ximmunology
650 0 4 _aTumor Cells, Cultured
700 1 _aVoyle, Roger B
700 1 _aWei, Bing-Yuan
700 1 _aMacDonald, H Robson
773 0 _tJournal of immunology (Baltimore, Md. : 1950)
_gvol. 170
_gno. 12
_gp. 5815-9
856 4 0 _uhttps://doi.org/10.4049/jimmunol.170.12.5815
_zAvailable from publisher's website
999 _c12578979
_d12578979